InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank21
Studio
Year-over-Year Change

Free cash flow yield

Latest
-244.86%
↑ 65% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-696.00%
Historical baseline
PeriodValueYoY Change
2025-244.86%+32.9%
2024-364.96%-11.3%
2023-328.02%+94.5%
2022-5930.44%-12840.9%
2021-45.83%-170.2%
2020-16.96%-45.2%
2019-11.68%-237.9%
2018-3.46%+53.5%
2017-7.43%-16.4%
2016-6.38%-